Status:

COMPLETED

Monitoring Subjects With Fluid-Management Issues In the Home Environment

Lead Sponsor:

Baxter Healthcare Corporation

Conditions:

Heart Failure

Hypertension

Eligibility:

All Genders

21-90 years

Brief Summary

This study is designed to validate ease-of-use for the CoVa Monitoring System, along with simple statistical parameters such as reproducibility and inter-subject agreement between test and reference d...

Detailed Description

The study has the following objectives: Objective 1: investigate ease-of-use associated with the CoVa Monitoring System: determine if subjects could use the test device on a daily basis, and if the c...

Eligibility Criteria

Inclusion

  • Subject is between 21 (twenty-one) and 90 (ninety) years of age at screening.
  • Subject will have a current prescription for a diuretic medication.
  • Subject and/or legally authorized person/representative is willing to undergo the Informed Consent process prior to enrollment in the study.
  • Subject is a candidate for this study based on the PI's opinion and knowledge of the subject's condition.

Exclusion

  • Subject is participating in another clinical study that may affect the results of either study.
  • Subject is unable or not willing to wear electrode patches as required.
  • Subject has skin sensitivity to adhesive or hydrogel materials used in electrode patches.
  • Subject has a pacemaker, implanted cardioverter-defibrillator, or ventricular assist device.
  • Subject is considered by the PI to be medically unsuitable for study participation.

Key Trial Info

Start Date :

April 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2014

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT02190877

Start Date

April 1 2014

End Date

May 1 2014

Last Update

July 23 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Riverside Meadows

Riverside, California, United States, 92505